共 50 条
- [43] Implications of discontinuing anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 956 - 956
- [44] Disparities in access to anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 (02): : 143 - 151
- [45] Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
- [47] EPIRETINAL MEMBRANES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Effect on Outcomes of Anti-vascular Endothelial Growth Factor Therapy RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (08): : 1540 - 1546
- [48] Value of Anti-Vascular Endothelial Growth Factor Gene Therapy for Neovascular Age-Related Macular Degeneration OPHTHALMOLOGY RETINA, 2021, 5 (04): : 357 - 364
- [49] Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2020, 50 (05): : 275 - 282